Description
BioMotiv is the venture creation and investment arm of the Harrington Discovery Institute, dedicated to advancing promising biomedical discoveries from academia into impactful medicines. BioMotiv forms and funds new companies around high‑potential science, providing capital, operational leadership, and development expertise.
Eligibility
• Academic or clinician‑led biomedical discoveries
• Pre‑company or newly formed startups
• Strong scientific validation with translational potential
• Willingness to partner in venture‑creation model
Process
Sourcing: Academic research, physician‑scientists, university tech transfer
Evaluation: Scientific merit, unmet medical need, translational potential
Engagement Model: Company formation, venture building, staged investment
Capital Structure: Equity investments deployed across milestones
What an Applicant can Obtain
✔ $500K–$5M+ in staged venture funding
✔ Company formation and operational leadership
✔ Drug development and translational expertise
✔ Access to clinical, regulatory, and academic networks
✔ Long‑term support through early development stages
